Okoli C, Van de Velde N, Richman B, et al Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries Sexually Transmitted Infections Published Online First: 30 July 2020. doi: 10.1136/sextrans-2020-054551 Abstract: Objectives ‘Undetectable equals Untransmittable’ (U=U) is an empowering message that may enable people...
July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...
SHINE SA, September 2020 The contraceptive implant (Implanon NXT) is one of the most effective contraceptives available. Along with the hormonal and copper IUDs, it is classified as Long Acting Reversible Contraception (LARC) which are recommended as first-line options for all people choosing to use contraception. SHINE SA wish to alert clinicians to important updated information about Implanon...
RACGP, 25th August 2020 The newly released suite consists of five intrauterine device (IUD) resources, including a checklist and patient confirmation form, patient pre- and post-insertion checklist, practitioner checklist and disclaimer. Current evidence-based options for pain relief during IUD procedures are provided as an appendix. Dr Amy Moten, Chair of the RACGP Specific Interests Sexual...
The Lancet, Volume 396, Issue 10250, 22–28 August 2020, Pages 565-582 Mauvais-Jarvis, F., et al Clinicians can encounter sex and gender disparities in diagnostic and therapeutic responses. These disparities are noted in epidemiology, pathophysiology, clinical manifestations, disease progression, and response to treatment. This Review discusses the fundamental influences of sex and gender as...
ASHM, August 2020 This training aims to provide participants with the knowledge and confidence to pursue the management of HCV in their primary care setting. Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030. This workshop will provide an overview of the management of HCV in primary care settings, including case finding, testing, patient...